Skip to main content
OpenTrials

Clinical trial condition

Blood Protein Disorders

Explore clinical trials studying Blood Protein Disorders. Study availability and eligibility vary by location and protocol.

3,039 public trials 566 recruiting studies
Refine in advanced search Browse all conditions

Blood Protein Disorders trial results

Completed

SU5416 in Treating Patients With Refractory or Relapsed Multiple Myeloma

NCT00006013

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations
  • H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States
  • University of Chicago Cancer Research Center Chicago, Illinois, United States
  • Fox Chase Cancer Center Philadelphia, Pennsylvania, United States
  • Vanderbilt-Ingram Cancer Center Nashville, Tennessee, United States
View Trial Details
Completed

Isotretinoin Plus Dexamethasone in Treating Patients With Multiple Myeloma

NCT00021359

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations
  • Hunterdon Regional Cancer Center Flemington, New Jersey, United States
  • Kimball Medical Center Lakewood, New Jersey, United States
  • South Jersey Regional Cancer Center Millville, New Jersey, United States
  • Fox Chase Cancer Center at Virtua Memorial Hospital Burlington County Mount Holly, New Jersey, United States
View all 18 locations
View Trial Details
Completed

Epoetin Alfa in Treating Anemia in Patients With Lymphoma, Chronic Lymphocytic Leukemia, or Multiple Myeloma and Anemia Caused By Chemotherapy

NCT00003341

Conditions
Anemia, Blood Protein Disorders, Cardiovascular Diseases, +33 more
Locations
  • Alta Bates Comprehensive Cancer Center Berkeley, California, United States
  • USC/Norris Comprehensive Cancer Center and Hospital Los Angeles, California, United States
  • Jonsson Comprehensive Cancer Center, UCLA Los Angeles, California, United States
  • Comprehensive Cancer Centers of the Desert Palm Springs, California, United States
View all 18 locations
View Trial Details
Completed

Dolastatin 10 in Treating Patients With Indolent Lymphoma, Waldenstrom's Macroglobulinemia, or Chronic Lymphocytic Leukemia

NCT00005579

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Chronic Disease, +24 more
Locations
  • Marlene and Stewart Greenebaum Cancer Center, University of Maryland Baltimore, Maryland, United States
  • Barbara Ann Karmanos Cancer Institute Detroit, Michigan, United States
  • Arthur G. James Cancer Hospital - Ohio State University Columbus, Ohio, United States
  • Vermont Cancer Center Burlington, Vermont, United States
View Trial Details

Related conditions